Page 2899 - Cote clinical veterinary advisor dogs and cats 4th

1546 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

Multiple organ dysfunction syndrome (MODS), Myocarditis, 675–676 Nasal discharge (Continued)
665–666, 666t, 1284.e2 causes of, 1253 sinus disorders and, 918
Chagas’, 675
sneezing and, 926
Multiple rib fractures. See Flail chest
VetBooks.ir Munchausen syndrome by proxy, 9 Myoclonic epilepsy, 661–663 Nasal flush, 1134.e5–1134.e7, 1134.e5f–1134.e7f
chagasic, 150
Nasal folliculitis and furunculosis, 15, 852
Mupirocin ointment, for acne, 16
Myoclonus, 661–663, 994–996
Murmurs, heart. See Heart murmurs
Nasal foreign bodies. See Respiratory tract, foreign bodies of
Muscarinic mushrooms, 666
canine distemper virus and, 271
Nasal lavage. See Nasal flush
Muscle biopsy, 1134.e1–1134.e2, 1134.e1f Myofibroblastic sarcoma, injection sites and, 550 Nasal hyperkeratosis, 215–216
Muscle condition score, 140.e1, 140.e2f–140.e3f Myoglobin, in urine, 1367 Nasal mites, 680.e2
Muscle contractures, 359.e2 Myoglobinuria, 1367–1368 reverse sneezing and, 887
Muscle relaxants. See also specific drugs hematuria versus, 1368 Nasal neoplasia, 680–681, 1255
centrally acting, and toxicosis, 108–110 Myopathy chondrosarcoma, 165–167
for intervertebral disc disease, 556 cardiac. See Cardiomyopathy lymphoma, 607
for neck pain, 683–684 caudal, acute, 149.e2 reverse sneezing and, 887
for spider envenomation, 929 classification of, 1253 sneezing and, 926
Muscle wasting, 1047 feline congenital, 1254 Nasal obstruction/discharge, chronic, in cats, 1255
Muscular disorders, tetraplegia/tetraparesis and, noninflammatory, 676.e2–676.e3 Nasal parakeratosis, 676
967 Myositis. See also Dermatomyositis of Labrador retriever, 215
Muscular dystrophy, 676.e2–676.e3, 1302 masticatory, 637–638 Nasal planum
Mushroom toxicosis, 442, 667–668 microorganisms associated with, 1254 cutaneous lupus erythematosus lesions of, 228–229,
Muzzle folliculitis and furunculosis. See Nasal folliculitis orbital disease and, 716–718 229f
and furunculosis Myotonia congenita, 676.e2 disorders of, 676–678
Myasthenia gravis, 668–670 Myringotomy, 404 hypopigmentation of, 196, 196f
as paraneoplastic syndrome, 754–756 Myxoma/myxosarcoma, spinal cord, 932 squamous cell carcinoma of, 939–942
thymoma and, 973–975 Myxomatous degeneration. See Myxomatous valve disease Nasal polyps. See Nasopharyngeal polyps
Myasthenia gravis titer. See Acetylcholine receptor Myxomatous valve disease Nasal sinus neoplasia, 1255
antibody test (ARAT) mitral/tricuspid regurgitation and, 658–661 Nasal sprays, 693.e3
Mycelex. See Clotrimazole treatment of, 99 Nasal tumor, reverse sneezing and, 887
Mycetoma, 247 Myxosarcoma, 927 Nasodigital hyperkeratosis, 215–216, 350
Mycobacterial culture, 1366–1367 Nasoesophageal/nasogastric feeding tube, 1107–1109,
Mycobacterial diseases, 670–671 N 1108f
Mycobacteriosis, atypical. See Mycobacterial diseases N-Acetyl-p-aminophenol (APAP). See Acetaminophen Nasojejunostomy tubes, 1111.e2
Mycobacterium avium, 670 N-Acetyl-p-benzoquinone, 11 Nasolacrimal system inflammation. See Dacryocystitis
Mycobacterium bovis, 670 N-Acetylcysteine Nasopharyngeal examination, 1125
Mycobacterium fortuitum, 670 for acetaminophen toxicosis, 11 Nasopharyngeal foreign bodies. See Respiratory tract,
Mycobacterium lepraemurium, 670 for acute hepatic injury, 443 foreign bodies of
Mycobacterium smegmatis, 670 administration and dosage of, 1200t–1201t, 1460 Nasopharyngeal inflammation, and reverse sneezing, 887
Mycobacterium tuberculosis, 670–671 for bacterial rhinitis, 890.e3 Nasopharyngeal polyps, 681–683, 683.e1f
Mycophenolate mofetil for hepatic encephalopathy seizures, 441 stridor/stertor and, 945
administration and dosage of, 1490 for hepatotoxicosis, 668 Nasopharyngeal stenosis, 683.e2–683.e3
for immune-mediated hemolytic anemia, 62 for lymphoplasmacytic rhinitis, 891 Nasopharyngeal tumor, reverse sneezing and, 887
for immune-mediated thrombocytopenia, 973 for mothball toxicosis, 661.e2 Natamycin, 210
for steroid-responsive meningitis-arteritis, 942 for zinc phosphide intoxication, 1052 Natriuretic peptide, N-Terminal pro-B-type, 1369–1370
Mycoplasma spp., 199, 671.e2–671.e3, 1367 N-(2–Mercaptopropionyl)-glycine (2–MPG), 1014.e3 Natural supplements toxicosis, 462–464, 463t–464t
abortion and, 2 N-Methyl-D-aspartate (NMDA) antagonists Naxcel. See Ceftiofur
infectious tracheobronchitis and, 988 for obsessive-compulsive disorder, 702 NCV. See Motor nerve conduction velocity (NCV)
M. haematominutum, 1172.e4t for osteoarthritis, 722 Nebulization, 1134–1135
M. haematoparvum, 1172.e2t–1172.e3t N-(Phosphonomethyl) glycine. See Glyphosate herbicide for bordetellosis, 126
M. haemocanis, 1172.e2t–1172.e3t toxicosis for canine influenza, 546
M. haemofelis, 60, 438–440, 439f, 1172.e4t N-Terminal pro-B-type natriuretic peptide (NT– for feline asthma, 85
M. turicensis, 1172.e4t proBNP), 1369–1370 for pneumocystosis, 793.e2
Mycoplasmosis, hemotropic, 438–440, 439f Nabumetone toxicosis, 696 Neck. See specific Cervical entries
Mycosis fungoides, 604.e5–604.e6. See also Cutaneous Nail disorders. See Claw disorders Neck pain, 1256
lymphoma Nailbed melanoma. See Subungual melanoma Neck ventroflexion, 684.e2–684.e3
Mycostatin. See Nystatin Naloxone Necrolytic migratory erythema. See Superficial necrolytic
Mycotic diseases. See Fungal infection administration and dosage of, 1496 dermatitis
Mycotoxins, in adulterated diets, 37t for opiates/opioids toxicosis, 711 Necrotizing cholecystitis, 165.e2
Mydriasis, 846 Naltrexone Necrotizing fasciitis, 684–686
Myelinolysis, 1047.e2 for acral lick dermatitis, 17 Necrotizing keratitis. See Corneal sequestration
Myelodysplasia, 671–673 administration and dosage of, 1496 Necrotizing scleritis, 304
Myelodysplastic syndrome, 1432a Namenda. See Memantine Necrotizing sialometaplasia, 894–897
Myelography Nanophyetus salmincola, 897–898 Necrotizing vasculitis. See Juvenile polyarteritis
in intervertebral disc disease, 556 Naphazoline toxicosis, 240–241, 661.e2 Needle biopsy. See Fine-needle aspiration (FNA)
in neck pain, 684 Naphthalene mothball toxicosis, 661.e2 Neem, 463t–464t
procedure for, 1134.e2–1134.e4, 1134.e3f–1134.e4f NAPQI. See N-acetyl-p-benzoquinone Negative fluid balance. See Dehydration
Myeloid leukemia Naprosyn. See Naproxen Neglect, 9
acute, 586–588 Naproxen toxicosis, 696 Nembutal. See Pentobarbital
chronic, 588–589 Narasin, 563.e2 Nemex. See Pyrantel pamoate
Myelolipoma, 591 Narcan. See Naloxone Neo-Synephrine. See Phenylephrine
Myeloma, multiple, 663–665, 893 Narcolepsy, 676.e1 Neochlamydia hartmannellae, 158
Myeloma proteins. See Bence-Jones urinary proteins seizures vs., 903 Neomycin
Myeloma-related disorder, 663 Nares, stenotic, brachycephalic airway syndrome and, 129 administration and dosage of, 1496
Myelomalacia, ascending-descending, 557 Nasal aspergillosis, 81–83 for garbage toxicosis, 376.e4
Myelopathy clotrimazole nasal infusion for, 1134.e7–1134.e8 for hepatic encephalopathy, 441
degenerative, 241–243, 242.e1f Nasal cavity Neonatal isoerythrolysis, 686–687
fibrocartilaginous embolic. See Fibrocartilaginous biopsy of, 680 Neonate. See also Kitten(s); Puppies
embolism computed tomography of, 83f, 1083.e2f expected weight gain in, 1142
hindlimb paresis and, 758 Nasal cavity disease, epistaxis and, 305–306 hand-rearing of, 1142
ischemic. See Fibrocartilaginous embolism Nasal cutaneous disorders, 676–678, 677f loss of, 687–689, 688f
Myelophthisis, 588 Nasal discharge, 678–680 tube feeding of, 1143
Myeloproliferative neoplasms, 588 aspergillosis and, 82 Neophobia, 787
Myelosuppression, chemotherapy and, 153–154 causes of, 1255 Neoplasia. See also Cancer; Carcinoma; Masses; Tumor(s);
Myiasis, 673–675, 674f chronic, in cats, 1255 specific neoplasms
Myleran. See Busulfan hemorrhagic. See Epistaxis abdominal. See Abdominal mass
Myocardial diseases, feline, 1253.e1 oronasal fistula and, 720 adrenocortical, 35–37
www.ExpertConsult.com